




Searching News Database: Macugen
HSMN NewsFeed - 13 Aug 2007
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
HSMN NewsFeed - 27 Jul 2007
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
HSMN NewsFeed - 23 Jul 2007
Merrimack Pharmaceuticals Names William Slichenmyer, M.D. Senior Vice President and Chief Medical Officer
Merrimack Pharmaceuticals Names William Slichenmyer, M.D. Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 13 Feb 2007
Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
HSMN NewsFeed - 2 Nov 2006
Enzon Pharmaceuticals Announces Second Investigational New Drug Application Approved for Novel rhMBL
Enzon Pharmaceuticals Announces Second Investigational New Drug Application Approved for Novel rhMBL
HSMN NewsFeed - 24 Oct 2006
Acuity Pharmaceuticals Appoints Denis O'Shaughnessy Senior Vice President of Clinical Development
Acuity Pharmaceuticals Appoints Denis O'Shaughnessy Senior Vice President of Clinical Development
HSMN NewsFeed - 21 Sep 2006
OSI Pharmaceuticals Launches Study of Tarceva(R) as Adjuvant Treatment for Non-Small Cell Lung Cancer
OSI Pharmaceuticals Launches Study of Tarceva(R) as Adjuvant Treatment for Non-Small Cell Lung Cancer
HSMN NewsFeed - 25 Jul 2006
FDA Approves Enzon's Oncaspar(R) for First-Line Use in Acute Lymphoblastic Leukemia
FDA Approves Enzon's Oncaspar(R) for First-Line Use in Acute Lymphoblastic Leukemia
HSMN NewsFeed - 6 Jul 2006
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
HSMN NewsFeed - 1 May 2006
OSI Pharmaceuticals Announces Management Changes to Its Eye Disease Business Team
OSI Pharmaceuticals Announces Management Changes to Its Eye Disease Business Team
HSMN NewsFeed - 17 Apr 2006
OSI Pharmaceuticals Announces Submission of New Drug Application for Tarceva(R) in Japan
OSI Pharmaceuticals Announces Submission of New Drug Application for Tarceva(R) in Japan
HSMN NewsFeed - 2 Feb 2006
OSI Pharmaceuticals Announces European Regulatory Approval for Macugen(R) (pegaptanib sodium injection)
OSI Pharmaceuticals Announces European Regulatory Approval for Macugen(R) (pegaptanib sodium injection)
HSMN NewsFeed - 1 Feb 2006
OSI Pharmaceuticals Announces Fourth Quarter Net Sales for Tarceva(R)'s International Launch
OSI Pharmaceuticals Announces Fourth Quarter Net Sales for Tarceva(R)'s International Launch
Additional items found! 40

Members Archive contains
40 additional stories matching:
Macugen
(Password required)
Macugen
(Password required)